Vitrolife AB (publ) (STO: VITR)
247.00
+22.80 (10.17%)
Aug 30, 2024, 5:29 PM CET
Vitrolife AB Revenue
Vitrolife AB had revenue of 941.00M SEK in the quarter ending June 30, 2024, with 3.98% growth. This brings the company's revenue in the last twelve months to 3.54B, up 3.60% year-over-year. In the year 2023, Vitrolife AB had annual revenue of 3.51B with 8.60% growth.
Revenue (ttm)
3.54B
Revenue Growth
+3.60%
P/S Ratio
9.46
Revenue / Employee
3.17M
Employees
1,115
Market Cap
33.44B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.51B | 278.00M | 8.60% |
Dec 31, 2022 | 3.23B | 1.55B | 92.39% |
Dec 31, 2021 | 1.68B | 435.43M | 34.96% |
Dec 31, 2020 | 1.25B | -234.56M | -15.85% |
Dec 31, 2019 | 1.48B | 328.78M | 28.56% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca PLC | 520.76B |
Swedish Orphan Biovitrum AB (publ) | 23.71B |
Getinge AB (publ) | 33.33B |
Sectra AB (publ) | 3.04B |
Camurus AB (publ) | 1.59B |
Medicover AB (publ) | 21.70B |
Elekta AB (publ) | 18.12B |
Vimian Group AB (publ) | 3.91B |